Cargando…
Long-Term Therapy With Wu-Ling-San, a Popular Antilithic Chinese Herbal Formula, Did Not Prevent Subsequent Stone Surgery: A Nationwide Population-Based Cohort Study
Traditional Chinese herbal medicine (CHM), which is widely used to treat pain and urolithiasis, is a promising therapy for urinary stone prevention. This study investigated the clinical efficacy of a popular CHM, Wu-Ling-San (WLS), in Taiwan for the prophylaxis of recurrent nephrolithiasis as assess...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5798738/ https://www.ncbi.nlm.nih.gov/pubmed/27932514 http://dx.doi.org/10.1177/0046958016681148 |
_version_ | 1783297890378055680 |
---|---|
author | Wu, San-Yuan Chen, Huey-Yi Tsai, Kao-Sung Chiang, Jen-Huai Muo, Chih-Hsin Sung, Fung-Chang Chen, Yung-Hsiang Chen, Wen-Chi |
author_facet | Wu, San-Yuan Chen, Huey-Yi Tsai, Kao-Sung Chiang, Jen-Huai Muo, Chih-Hsin Sung, Fung-Chang Chen, Yung-Hsiang Chen, Wen-Chi |
author_sort | Wu, San-Yuan |
collection | PubMed |
description | Traditional Chinese herbal medicine (CHM), which is widely used to treat pain and urolithiasis, is a promising therapy for urinary stone prevention. This study investigated the clinical efficacy of a popular CHM, Wu-Ling-San (WLS), in Taiwan for the prophylaxis of recurrent nephrolithiasis as assessed by surgical stone treatment via a nationwide population-based cohort study. The National Health Insurance Research Database, 2000–2010, which included one million patient records. All patients diagnosed with stone disease at the beginning of the study. The matched controls (4-fold the number of WLS patients) were stone patients who did not take WLS. Data analysis included the stone surgeries following the first treatment. We enrolled 11 900 patients with stone disease, and the incidence of stone patients in this database was 1.19%. The prevalence of comorbidities such as benign prostate hyperplasia, chronic kidney disease, diabetes mellitus, and urinary tract infection, but not hypertension, was significantly higher in WLS users. Several patients in both groups were prescribed potassium citrate. The stone treatment rate was significantly higher in WLS users (17.85%) than in the non-WLS users (14.47%). WLS users with an associated comorbidity had a higher treatment rate than the non-WLS users: 21.05% versus 16.70%, respectively. The surgery rate for upper urinary tract stones was higher in WLS users than in the non-WLS users (adjusted hazard ratio, 1.28; 95% confidence interval, 1.08-1.52; P < .05). The stone treatment rate (52.79%) was significantly higher in patients who used a very high amount of WLS (adjusted hazard ratio, 3.02; 95% confidence interval, 2.30-3.98). Stone patients using a high amount of WLS use had a high stone surgical rate. Long-term therapy with WLS did not have a preventive effect on stone surgical treatment. Long-term potassium citrate therapy as a preventive measure appeared to be underutilized in this study. |
format | Online Article Text |
id | pubmed-5798738 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-57987382018-02-12 Long-Term Therapy With Wu-Ling-San, a Popular Antilithic Chinese Herbal Formula, Did Not Prevent Subsequent Stone Surgery: A Nationwide Population-Based Cohort Study Wu, San-Yuan Chen, Huey-Yi Tsai, Kao-Sung Chiang, Jen-Huai Muo, Chih-Hsin Sung, Fung-Chang Chen, Yung-Hsiang Chen, Wen-Chi Inquiry Healthcare in the National Health Insurance System in Taiwan Traditional Chinese herbal medicine (CHM), which is widely used to treat pain and urolithiasis, is a promising therapy for urinary stone prevention. This study investigated the clinical efficacy of a popular CHM, Wu-Ling-San (WLS), in Taiwan for the prophylaxis of recurrent nephrolithiasis as assessed by surgical stone treatment via a nationwide population-based cohort study. The National Health Insurance Research Database, 2000–2010, which included one million patient records. All patients diagnosed with stone disease at the beginning of the study. The matched controls (4-fold the number of WLS patients) were stone patients who did not take WLS. Data analysis included the stone surgeries following the first treatment. We enrolled 11 900 patients with stone disease, and the incidence of stone patients in this database was 1.19%. The prevalence of comorbidities such as benign prostate hyperplasia, chronic kidney disease, diabetes mellitus, and urinary tract infection, but not hypertension, was significantly higher in WLS users. Several patients in both groups were prescribed potassium citrate. The stone treatment rate was significantly higher in WLS users (17.85%) than in the non-WLS users (14.47%). WLS users with an associated comorbidity had a higher treatment rate than the non-WLS users: 21.05% versus 16.70%, respectively. The surgery rate for upper urinary tract stones was higher in WLS users than in the non-WLS users (adjusted hazard ratio, 1.28; 95% confidence interval, 1.08-1.52; P < .05). The stone treatment rate (52.79%) was significantly higher in patients who used a very high amount of WLS (adjusted hazard ratio, 3.02; 95% confidence interval, 2.30-3.98). Stone patients using a high amount of WLS use had a high stone surgical rate. Long-term therapy with WLS did not have a preventive effect on stone surgical treatment. Long-term potassium citrate therapy as a preventive measure appeared to be underutilized in this study. SAGE Publications 2016-12-07 /pmc/articles/PMC5798738/ /pubmed/27932514 http://dx.doi.org/10.1177/0046958016681148 Text en © The Author(s) 2016 http://creativecommons.org/licenses/by-nc/3.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page(https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Healthcare in the National Health Insurance System in Taiwan Wu, San-Yuan Chen, Huey-Yi Tsai, Kao-Sung Chiang, Jen-Huai Muo, Chih-Hsin Sung, Fung-Chang Chen, Yung-Hsiang Chen, Wen-Chi Long-Term Therapy With Wu-Ling-San, a Popular Antilithic Chinese Herbal Formula, Did Not Prevent Subsequent Stone Surgery: A Nationwide Population-Based Cohort Study |
title | Long-Term Therapy With Wu-Ling-San, a Popular Antilithic Chinese Herbal Formula, Did Not Prevent Subsequent Stone Surgery: A Nationwide Population-Based Cohort Study |
title_full | Long-Term Therapy With Wu-Ling-San, a Popular Antilithic Chinese Herbal Formula, Did Not Prevent Subsequent Stone Surgery: A Nationwide Population-Based Cohort Study |
title_fullStr | Long-Term Therapy With Wu-Ling-San, a Popular Antilithic Chinese Herbal Formula, Did Not Prevent Subsequent Stone Surgery: A Nationwide Population-Based Cohort Study |
title_full_unstemmed | Long-Term Therapy With Wu-Ling-San, a Popular Antilithic Chinese Herbal Formula, Did Not Prevent Subsequent Stone Surgery: A Nationwide Population-Based Cohort Study |
title_short | Long-Term Therapy With Wu-Ling-San, a Popular Antilithic Chinese Herbal Formula, Did Not Prevent Subsequent Stone Surgery: A Nationwide Population-Based Cohort Study |
title_sort | long-term therapy with wu-ling-san, a popular antilithic chinese herbal formula, did not prevent subsequent stone surgery: a nationwide population-based cohort study |
topic | Healthcare in the National Health Insurance System in Taiwan |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5798738/ https://www.ncbi.nlm.nih.gov/pubmed/27932514 http://dx.doi.org/10.1177/0046958016681148 |
work_keys_str_mv | AT wusanyuan longtermtherapywithwulingsanapopularantilithicchineseherbalformuladidnotpreventsubsequentstonesurgeryanationwidepopulationbasedcohortstudy AT chenhueyyi longtermtherapywithwulingsanapopularantilithicchineseherbalformuladidnotpreventsubsequentstonesurgeryanationwidepopulationbasedcohortstudy AT tsaikaosung longtermtherapywithwulingsanapopularantilithicchineseherbalformuladidnotpreventsubsequentstonesurgeryanationwidepopulationbasedcohortstudy AT chiangjenhuai longtermtherapywithwulingsanapopularantilithicchineseherbalformuladidnotpreventsubsequentstonesurgeryanationwidepopulationbasedcohortstudy AT muochihhsin longtermtherapywithwulingsanapopularantilithicchineseherbalformuladidnotpreventsubsequentstonesurgeryanationwidepopulationbasedcohortstudy AT sungfungchang longtermtherapywithwulingsanapopularantilithicchineseherbalformuladidnotpreventsubsequentstonesurgeryanationwidepopulationbasedcohortstudy AT chenyunghsiang longtermtherapywithwulingsanapopularantilithicchineseherbalformuladidnotpreventsubsequentstonesurgeryanationwidepopulationbasedcohortstudy AT chenwenchi longtermtherapywithwulingsanapopularantilithicchineseherbalformuladidnotpreventsubsequentstonesurgeryanationwidepopulationbasedcohortstudy |